MynxGrip and Mynx Control Vascular Closure Device
FDA premarket approval P040044/S095 · decided 2023-10-17
Approval details
- PMA number
- P040044
- Supplement
- S095
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- MynxGrip and Mynx Control Vascular Closure Device
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cordis US Corporation
- Date received
- 2023-09-18
- Decision date
- 2023-10-17
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Miami Lakes, FL
- Statement
- the removal of receiving inspections for several components of the MynxGrip Vascular Closure Device and Mynx Control Vascular Closure Device
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.